A study analyzing serum samples from six patients with refractory SLE before and after CAR-T therapy revealed decreased levels of IL-6 and TNF-α, accompanied by increased levels of IL-7 and BAFF, as well as a significant reduction in SLE-related antibodies (34). The gene discussed is IL6; the disease is systemic lupus erythematosus.